These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16431301)

  • 1. Hepatocellular carcinoma: patients with increasing alpha-fetoprotein but no mass on ultrasound.
    Llovet JM
    Clin Gastroenterol Hepatol; 2006 Jan; 4(1):29-35. PubMed ID: 16431301
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical course of chronic hepatitis C in patients with very high serum alpha-fetoprotein levels and normal hepatic imaging.
    Gonzalez SA; Jacobson IM
    Am J Gastroenterol; 2005 Apr; 100(4):977-8. PubMed ID: 15784045
    [No Abstract]   [Full Text] [Related]  

  • 3. [Should we screen for hepatocellular carcinoma?].
    Trinchet JC; Ganne-Carrié N
    Gastroenterol Clin Biol; 2006; 30(6-7):880-6. PubMed ID: 16885873
    [No Abstract]   [Full Text] [Related]  

  • 4. Spontaneous regression of hepatocellular carcinoma.
    Kondo S; Okusaka T; Ueno H; Ikeda M; Morizane C
    Int J Clin Oncol; 2006 Oct; 11(5):407-11. PubMed ID: 17058140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combination of α-fetoprotein, midkine, thioredoxin and a metabolite for predicting hepatocellular carcinoma.
    Omran MM; Farid K; Omar MA; Emran TM; El-Taweel FM; Tabll AA
    Ann Hepatol; 2020; 19(2):179-185. PubMed ID: 31648804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-fetoprotein in hepatocellular carcinoma surveillance: wake not the dead.
    Giannini EG; Farinati F; Trevisani F
    Hepatology; 2011 Jul; 54(1):376-7. PubMed ID: 21710475
    [No Abstract]   [Full Text] [Related]  

  • 7. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis.
    Oka H; Kurioka N; Kim K; Kanno T; Kuroki T; Mizoguchi Y; Kobayashi K
    Hepatology; 1990 Oct; 12(4 Pt 1):680-7. PubMed ID: 1698703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis].
    Denis I; Beaudonnet A; Pichot J; Roubille M; Gelineau M
    Ann Biol Clin (Paris); 2000; 58(1):85-90. PubMed ID: 10673618
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluating patients with cirrhosis for hepatocellular carcinoma: value of clinical symptomatology, imaging and alpha-fetoprotein.
    Paul SB; Gulati MS; Sreenivas V; Madan K; Gupta AK; Mukhopadhyay S; Acharya SK
    Oncology; 2007; 72 Suppl 1():117-23. PubMed ID: 18087192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Fetoprotein in hepatocellular carcinoma surveillance: mend it but do not end it.
    El-Serag HB; Kanwal F
    Clin Gastroenterol Hepatol; 2013 Apr; 11(4):441-3. PubMed ID: 23376321
    [No Abstract]   [Full Text] [Related]  

  • 11. Markedly increased alpha-fetoprotein concentration in serum in alcoholic liver disease: malignant tumor or nonneoplastic changes?
    Kaczynski J; Jagenburg R; Lindstedt G; Wallerstedt S
    Clin Chem; 1992 May; 38(5):710-6. PubMed ID: 1374690
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis.
    Arguedas MR; Chen VK; Eloubeidi MA; Fallon MB
    Am J Gastroenterol; 2003 Mar; 98(3):679-90. PubMed ID: 12650806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA.
    El-Serag HB; Kramer JR; Chen GJ; Duan Z; Richardson PA; Davila JA
    Gut; 2011 Jul; 60(7):992-7. PubMed ID: 21257990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extreme elevation of serum alpha fetoprotein in decompensated cirrhosis without HCC: an ominous sign.
    Senturk H; Cumali R
    Int J Biol Markers; 2007; 22(1):19-23. PubMed ID: 17393357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
    Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K
    Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corelation of serum alpha fetoprotein and tumor size in hepatocellular carcinoma.
    Abbasi A; Bhutto AR; Butt N; Munir SM
    J Pak Med Assoc; 2012 Jan; 62(1):33-6. PubMed ID: 22352098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the albumin-gamma-glutamyltransferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis.
    Pompili M; Addolorato G; Pignataro G; Rossi C; Zuppi C; Covino M; Grieco A; Gasbarrini G; Rapaccini GL
    J Gastroenterol Hepatol; 2003 Mar; 18(3):288-95. PubMed ID: 12603529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer-aided assessment of hepatic contour abnormalities as an imaging biomarker for the prediction of hepatocellular carcinoma development in patients with chronic hepatitis C.
    Goshima S; Kanematsu M; Kondo H; Watanabe H; Noda Y; Fujita H; Bae KT
    Eur J Radiol; 2015 May; 84(5):811-5. PubMed ID: 25650331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasonography and alpha-fetoprotein in diagnosis of hepatocellular carcinoma in cirrhosis.
    Maringhini A; Cottone M; Sciarrino E; Marcenó MP; La Seta F; Fusco G; Rinaldi F; Pagliaro L
    Dig Dis Sci; 1988 Jan; 33(1):47-51. PubMed ID: 2448095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of screening methods for hepatocellular carcinomas in patients with cirrhosis.
    Okano H; Shiraki K; Inoue H; Ito T; Yamanaka T; Deguchi M; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Nakano T
    Anticancer Res; 2001; 21(4B):2979-82. PubMed ID: 11712797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.